A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients G. Moreno, M. Ruiz-Botella, I. Martín-Loeches, J. Gómez Álvarez, M. Jiménez Herrera, M. Bodí, F. Armestar, A. Marques Parra, Á. Estella, S. Trefler, R. Jorge García, J. Murcia Paya, P. Vidal Cortes, E. Díaz, R. Ferrer, A. Albaya-Moreno, L. Socias-Crespi, J.M. Bonell Goytisolo, S. Sancho Chinesta, A. Loza, L. Forcelledo Espina, J.C. Pozo Laderas, M. deAlba-Aparicio, L. Sánchez Montori, I. Vallverdú Perapoch, V. Hidalgo, V. Fraile Gutiérrez, A.M. Casamitjana Ortega, F. Martín Serrano, M. Nieto, M. Blasco Cortes, J. Marín-Corral, J. Solé-Violán, A. Rodríguez

Evolution over a 15-year period of the clinical characteristics and outcomes of critically ill patients with severe community-acquired pneumonia J. Vallés, E. Diaz, I. Martín-Loeches, N. Bacelar, P. Saludes, J. Lema, M. Gallego, D. Fontanals, A. Artigas

Risk factors and outcome of acute kidney injury in critically ill patients with SARS-CoV-2 pneumonia: a multicenter study Iban Oliva, Cristina Ferré, Xavier Daniel, Marc Cartanyà, Christian Villavicencio, Melina Salgado, Loreto Vidaur, Elisabeth Papiol, FJ González de Molina, María Bodí, Manuel Herrera, Alejandro Rodríguez